Caladrius Biosciences, Inc. (LSTA) Reports Q4 Loss of $0.76/sh
Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q4 EPS of ($0.76), versus ($1.70) reported last year.
For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.
